Gabapentin
- Product NDC
- 43353-862
- 11-digit product format
- 433530862
- Labeler code
- 43353
- Product ID
- 43353-862_19801231-00a9-4772-b3b1-9be1ac7c1b86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA078787
- Marketing category
- ANDA
- Marketing start
- 2008-01-31
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-862 | GABAPENTIN CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 3 | Legacy NDC | 20171029_f041f43e-dbd8-4cbf-ad77-f0d9c6b8ffa8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-862-60 | 43353086260 | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-862-60) | 90 capsule | 2014-11-06 | 0000-00-00 | No | No | Current |
| 43353-862-80 | 43353086280 | 180 CAPSULE in 1 BOTTLE, PLASTIC (43353-862-80) | 180 capsule | 2016-01-26 | 0000-00-00 | No | No | Current |
| 43353-862-92 | 43353086292 | 270 CAPSULE in 1 BOTTLE, PLASTIC (43353-862-92) | 270 capsule | 2013-08-16 | 0000-00-00 | No | No | Current |
| 43353-862-98 | 43353086298 | 540 CAPSULE in 1 BOTTLE, PLASTIC (43353-862-98) | 540 capsule | 2013-08-16 | 0000-00-00 | No | No | Current |